Stocks and Investing Stocks and Investing
Wed, May 10, 2023
Tue, May 9, 2023

Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $59 on, May 9th, 2023


Published on 2024-10-28 03:34:20 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $55 to $59 on, May 9th, 2023.

Vamil, nor any peers, have made any analyst calls on ANIP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources